Why Ferritin Thresholds for Iron Deficiency Differ

One report labels ferritin below 15 ng/mL as iron deficiency. Another guideline uses 45. A heart-failure pathway uses 100, while kidney guidance interprets ferritin alongside transferrin saturation and dialysis status. The numbers can look contradictory until the question behind each cutoff is made explicit.

Ferritin is the main intracellular iron-storage protein, and a small amount circulates in blood. A very low serum ferritin is strong evidence that iron stores are depleted. Ferritin also rises during inflammation, infection, liver injury, kidney disease, malignancy, and other states. In those settings, an apparently normal or high result can coexist with iron that is unavailable to the bone marrow and other tissues.

Thresholds therefore differ for principled reasons. Some identify depleted stores in an apparently healthy population; some favor sensitivity in a patient who already has anemia; some define eligibility for a treatment studied in heart failure; and some manage iron delivery in chronic kidney disease. Interpretation begins with the population and the purpose, not with choosing the largest or smallest number you can find.

What ferritin measures#

Ferritin stores iron in a soluble, controlled form inside cells. Serum ferritin generally tracks the size of body iron stores, especially at the low end. When stores are exhausted, ferritin falls. This makes a distinctly low value one of the most specific routinely available findings for iron deficiency.

The relation becomes less direct as ferritin rises. Inflammatory signals increase ferritin production and reduce iron release from storage cells through the hepcidin pathway. Liver cells can release ferritin during injury. Kidney disease alters inflammation, losses, erythropoiesis, and treatment response. A value of 100 ng/mL can mean different things in a healthy person, someone with an acute infection, and someone receiving dialysis.

Ferritin is reported as nanograms per milliliter or micrograms per liter. These units are numerically equivalent: 1 ng/mL equals 1 microgram/L. Unit conversion does not explain a 15-versus-45 disagreement; the clinical framework does.

Iron deficiency and anemia are different states#

Iron deficiency begins when iron stores and available iron become inadequate for the body's needs. Hemoglobin can remain within its reference range early in that process. Symptoms such as fatigue, reduced exercise tolerance, restless legs, hair changes, or cognitive difficulty are nonspecific and cannot establish deficiency without evaluation.

Iron deficiency anemia is a later hematologic expression in which iron limitation contributes to low hemoglobin. Red cells may become small and contain less hemoglobin, but early iron-deficiency anemia can be normocytic. Other conditions can also produce microcytosis or anemia.

A guideline written for "people with anemia" starts with a higher pretest probability than a population survey. Raising the ferritin cutoff can identify more true cases, at the price of including more people whose anemia has another cause; that tradeoff may be sensible when missing gastrointestinal blood loss is consequential and follow-up testing can resolve uncertainty.

Why WHO uses a low reference threshold#

The 2020 World Health Organization guideline addresses assessment of iron status in individuals and populations. In apparently healthy adolescents, adults, and older adults, ferritin below 15 micrograms/L indicates iron deficiency. The low cutoff is specific for depleted stores and supports comparable population estimates.

WHO does not claim that ferritin of 15 or higher excludes deficiency in every clinical setting; its guideline specifically addresses infection and inflammation, recommends measuring inflammatory markers in population surveys where relevant, and provides adjusted interpretation. In adults with infection or inflammation, WHO notes that a ferritin concentration below 70 micrograms/L may indicate iron deficiency.

That higher figure is not an instruction to diagnose every inflamed adult below 70 with iron deficiency. It reflects the upward distortion created by inflammation and must be used with the guideline's population and methods. Clinical evaluation often adds transferrin saturation, blood counts, inflammatory markers, organ function, and evidence of blood loss.

Why AGA recommends 45 in anemia#

The American Gastroenterological Association's 2020 guideline addresses adults with anemia who are being evaluated for iron deficiency and possible gastrointestinal causes, and it recommends a ferritin cutoff of 45 ng/mL rather than 15 when using ferritin to diagnose iron deficiency in this population.

The technical review found that 45 offered substantially greater sensitivity for iron deficiency than 15 while retaining useful specificity, which matters because iron deficiency anemia can be the first sign of gastrointestinal bleeding, celiac disease, malignancy, or another treatable disorder. A very specific cutoff that misses many cases can delay the etiologic evaluation.

The AGA value is not a universal lower boundary for all people, symptoms, or treatment decisions. It assumes anemia is present and is embedded in a gastrointestinal evaluation pathway. Inflammation and chronic disease can still require additional tests.

Transferrin saturation asks a different question#

Transferrin carries iron through plasma. Transferrin saturation, or TSAT, estimates the percentage of iron-binding sites occupied by iron. It is calculated from serum iron and an iron-binding measure. A low TSAT suggests that limited iron is immediately available for red-cell production and tissues.

Serum iron varies during the day and with meals, illness, and recent iron treatment. Transferrin changes with inflammation, nutrition, liver function, and pregnancy. TSAT is therefore not a perfect gold standard. It adds a dimension that ferritin alone lacks: circulating availability rather than storage.

A pattern of low ferritin and low TSAT supports systemic iron deficiency. Low TSAT with normal or high ferritin can occur when inflammation-driven hepcidin traps iron in storage cells, a state the 2026 KDIGO guideline calls iron-restricted erythropoiesis. The older term "functional iron deficiency" is still widely recognized, but the newer language describes the physiology more directly.

Chronic kidney disease changes both biology and thresholds#

People with chronic kidney disease can have reduced erythropoietin, inflammation, blood loss, frequent laboratory sampling, dialysis-related losses, reduced intake, impaired absorption, and medicines that affect red-cell production. Ferritin may be elevated even when usable iron is limited.

KDIGO's final 2026 anemia guideline therefore uses ferritin and TSAT together and distinguishes people not receiving dialysis from those receiving hemodialysis. It describes systemic iron deficiency with low TSAT and low ferritin, using examples such as ferritin below 100 ng/mL in nondialysis CKD and below 200 in hemodialysis with TSAT below 20%. It also recognizes iron-restricted erythropoiesis when TSAT is low despite higher ferritin.

Treatment thresholds and stopping rules depend on CKD stage, dialysis, hemoglobin, current therapy, infection, and expected benefit. They should not be copied into a healthy population. KDIGO also emphasizes that common thresholds do not correlate perfectly with bone-marrow iron or hemoglobin response, which is why trends and response remain important.

Heart-failure definitions are tied to treatment evidence#

Iron deficiency can worsen symptoms and exercise capacity in heart failure even without classic anemia. Trials of intravenous iron enrolled participants using operational definitions that combined ferritin and TSAT. Guidelines then use related criteria to identify people who resemble studied populations and may benefit.

NICE's heart-failure guideline, updated in 2025, recommends checking ferritin, TSAT, and hemoglobin in heart failure with reduced ejection fraction. It says to consider specified intravenous iron preparations when hemoglobin is below 150 g/L and iron deficiency is defined as TSAT below 20% or ferritin below 100 ng/mL.

This is an action threshold within a particular heart-failure treatment recommendation. It should not be read as proof that every person with ferritin 99 has depleted total-body stores. NICE also says not to assume iron deficiency anemia is caused by heart failure and to investigate alternative causes.

Reference ranges and decision limits are not the same#

A laboratory reference interval commonly describes values observed in a selected reference population, and a clinical decision limit is chosen because crossing it changes the probability of disease or the expected value of an action. Guidelines often use decision limits.

The distinction matters when a report marks your ferritin "normal" but a clinician still considers iron deficiency likely. The laboratory flag may use a low population boundary, while the clinical pathway uses a more sensitive value because anemia, inflammation, pregnancy, kidney disease, or heart failure changes the question.

Local assays and intervals also differ. Ferritin methods are standardized imperfectly, and results near a cutoff have biological and analytical variation. Repeating a borderline result, or reading the trend, may tell you more than treating one value as exact.

Why a high ferritin does not mean iron overload by itself#

High ferritin can accompany iron overload, but it is nonspecific. Infection, inflammatory disease, liver injury, alcohol-related liver disease, metabolic liver disease, malignancy, kidney disease, and recent iron administration can raise it. TSAT, liver tests, blood count, clinical history, genetic context, and sometimes imaging help you distinguish causes.

Conversely, inflammation can mask iron deficiency by pushing ferritin upward. The combined pattern matters. You can have iron-restricted red-cell production with ferritin that appears ample.

Both errors are risky: assuming all high ferritin means excess iron can trigger unnecessary testing, while treating every high ferritin as inflammation can miss true overload. The direction of investigation depends on the whole iron panel and clinical setting.

The cause matters more than the replacement alone#

Iron deficiency is a finding, not the final diagnosis. Common mechanisms include menstrual or other uterine blood loss, gastrointestinal bleeding, frequent blood donation, pregnancy-related need, inadequate intake, celiac disease, inflammatory bowel disease, bariatric surgery, and other forms of malabsorption. Several can coexist.

Age, sex, menstrual pattern, pregnancy status, medicines, gastrointestinal symptoms, diet, surgery history, family history, and visible bleeding guide the evaluation. In adults with iron deficiency anemia, gastrointestinal investigation may be necessary even when no digestive symptom is present, and a response to iron confirms that iron was useful but does not prove why stores became low.

Unsupervised long-term supplementation can obscure ongoing blood loss, cause gastrointestinal adverse effects, interact with medicines, and create excess in susceptible people. Oral and intravenous iron have different indications and risks. Selection, dose, monitoring, and duration require a patient-specific plan.

A decision-first reading of the panel#

Start by naming the question: depleted stores, cause of anemia, treatment eligibility, response to therapy, or possible overload. Then identify the population and conditions that alter ferritin. Review the complete blood count, ferritin, TSAT, inflammatory state, kidney and liver context, and prior results.

Ask whether the value is far below a threshold or close to it. A ferritin of 5 carries different diagnostic weight from 44 in a person with anemia and inflammation. Check whether recent illness, iron treatment, transfusion, or laboratory timing could affect your interpretation.

Finally, connect the result to two plans: replenish iron when appropriate and investigate the cause. A threshold is useful when it organizes those decisions. It becomes misleading when it is detached from them.

Safety boundaries#

Black tarry stools, vomiting blood, heavy uncontrolled bleeding, fainting, chest pain, shortness of breath at rest, a very rapid heartbeat, confusion, or severe weakness can signal significant blood loss or anemia and require urgent assessment. Pregnancy with bleeding or severe symptoms also needs prompt care.

Ferritin results should not be used alone to start intravenous iron, postpone evaluation, or diagnose overload. People with kidney disease, heart failure, inflammatory disease, pregnancy, or recurrent deficiency need interpretation within the relevant care pathway.

The apparent disagreement among cutoffs is not a failure of laboratory medicine. It is a reminder that the same biomarker can support several different decisions.